Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.42 |
| ▸ | CASR | P41180 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | PDE2A | O00408 | 1/20 | 0.41 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7937983 | 0.93 | GPR3 (0.47) | GPR3GAAMAPTEPHX2HSD11B1 | |
| SCHEMBL7938385 | 0.93 | KIF11 (0.50) | GPR3GAAMAPTEPHX2HSD11B1 | |
| SCHEMBL254957 | 0.88 | MAPT (0.56) | GPR3GAAMAPTEPHX2L3MBTL1 | |
| SCHEMBL7929139 | 0.87 | SLC6A4 (0.50) | GPR3GAAMAPTL3MBTL1CASR | |
| SCHEMBL7940692 | 0.87 | CHRNA7 (0.52) | GPR3GAAMAPTEPHX2HSD11B1 | |
| SCHEMBL7940638 | 0.85 | TRPV1 (0.44) | GPR3GAAMAPTEPHX2HSD11B1 | |
| SCHEMBL7929077 | 0.85 | ESR1 (0.43) | GPR3GAAMAPTEPHX2HSD11B1 | |
| SCHEMBL7937431 | 0.83 | HSD11B1 (0.49) | GAAHSD11B1KIF11 | |
| SCHEMBL12204657 | 0.83 | PDE2A (0.51) | GPR3GAAMAPTEPHX2HSD11B1 | |
| SCHEMBL7929195 | 0.83 | NPC1 (0.54) | GAAEPHX2HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117239230-B | Lithium ion battery electrolyte additive, lithium ion battery electrolyte and preparation method of lithium ion battery electrolyte additive | 哈尔滨工业大学 | 2024-06-04 | — | — | CN | claimed |
| CN-117239230-A | Lithium ion battery electrolyte additive, lithium ion battery electrolyte and preparation method of lithium ion battery electrolyte additive | 哈尔滨工业大学 | 2023-12-15 | — | — | CN | claimed |
| CN-116864809-A | Lithium ion battery electrolyte and application thereof | 远景动力技术(江苏)有限公司 | 2023-10-10 | — | — | CN | claimed |
| US-20210079534-A1 | METHOD, CELL, AND ELECTROLYTE FOR DINITROGEN CONVERSION | MONASH UNIVERSITY (AU) | 2021-03-18 | — | — | US | claimed |
| EP-3658505-A1 | METHOD, CELL AND ELECTROLYTE FOR DINITROGEN CONVERSION | Monash University (AU) | 2020-06-03 | — | — | EP | claimed |
| CN-110869319-A | Method for dinitrogen conversion, battery and electrolyte | 莫纳什大学 | 2020-03-06 | — | — | CN | claimed |
| WO-2012054782-A2 | FLUOROALKOXYLATION OF ORGANIC COMPOUNDS | PRESIDENTS AND FELLOWS OF HARVARD COLLEGE (US) | 2012-04-26 | — | — | WO | claimed |
| CN-117239230-B | Lithium ion battery electrolyte additive, lithium ion battery electrolyte and preparation method of lithium ion battery electrolyte additive | 哈尔滨工业大学 | 2024-06-04 | — | — | CN | disclosed |
| CN-117720550-A | Synthesis method of (S) -3-methyl-4-oxo-2-oxa-8-azaspiro [4.5] decane-8-carboxylic acid tert-butyl ester | 深圳市华先医药科技有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-117239230-A | Lithium ion battery electrolyte additive, lithium ion battery electrolyte and preparation method of lithium ion battery electrolyte additive | 哈尔滨工业大学 | 2023-12-15 | — | — | CN | disclosed |
| US-20230346753-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO HEALTH, INC. | 2023-11-02 | — | — | US | disclosed |
| WO-2023196254-A1 | ALUMINUM-ETHER-BASED COMPOSITION FOR BATTERIES AND AMBIENT TEMPERATURE ALUMINUM DEPOSITION | BATTELLE MEMORIAL INSTITUTE (US) | 2023-10-12 | — | — | WO | disclosed |
| EP-3788038-B1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC (US) | 2023-10-11 | — | — | EP | disclosed |
| EP-0802173-A1 | Process for producing heterocylic aromatic amine or arylamine | Tosoh Corporation (JP) | 1997-10-22 | — | — | EP | disclosed |
| EP-0315862-B1 | Aromatically fluorinated fluoromethoxy- and fluoromethylthio-amino benzenes and their preparation | BAYER AG (DE) | 1994-04-13 | — | — | EP | disclosed |
| EP-0318704-B1 | 3-CYANO-4-PHENYL-PYRROLE DERIVATIVES | BAYER AG (DE) | 1992-12-02 | — | — | EP | disclosed |
| US-5015757-A | Fungicides | BAYER AKTIENGESELLSCHAFT (DE) | 1991-05-14 | — | — | US | disclosed |
| US-4960789-A | FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1990-10-02 | — | — | US | disclosed |
| EP-0315862-A2 | Aromatically fluorinated fluoromethoxy- and fluoromethylthio-amino benzenes and their preparation | BAYER AG (DE) | 1989-05-17 | — | — | EP | disclosed |
| EP-0273409-A1 | Nitrohaloalkoxybenzenes, processes for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346753-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, NNMT, NQO1 | GPR3 2010/4885GAA 624/4885MAPT 519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.